Abstract: In this study, we aimed to evaluate the toxic effects, changes in life span, and expression of various metabolism-related genes in Caenorhabditis elegans, using RNA interference (RNAi) and mutant strains, after 3-bromopyruvate (3-BrPA) treatment. C. elegans was treated with various concentrations of 3-BrPA on nematode growth medium (NGM) plates, and their survival was monitored every 24 h. The expression of genes related to metabolism was measured by the real-time fluorescent quantitative polymerase chain reaction (qPCR). Nematode survival in the presence of 3-BrPA was also studied after silencing three hexokinase (HK) genes. The average life span of C. elegans cultured on NGM with 3-BrPA was shortened to 5.7 d compared with 7.7 d in the control group. hxk-1, hxk-2, and hxk-3 were overexpressed after the treatment with 3-BrPA. After successfully interfering hxk-1, hxk-2, and hxk-3, the 50% lethal concentration (LC₅₀) of all mutant nematodes decreased with 3-BrPA treatment for 24 h compared with that of the control. All the cyp35 genes tested were overexpressed, except cyp-35B3. The induction of cyp-35A1 expression was most obvious. The LC₅₀ values of the mutant strains cyp-35A1, cyp-35A2, cyp-35A4, cyp-35B3, and cyp-35C1 were lower than that of the control. Thus, the toxicity of 3-BrPA is closely related to its effect on hexokinase metabolism in nematodes, and the cyp-35 family plays a key role in the metabolism of 3-BrPA.

3-溴丙酮酸对秀丽隐杆线虫的毒性和代谢的影响

[1]Alcántar-Aguirre FC, Chagolla A, Tiessen A, et al., 2013. ATP produced by oxidative phosphorylation is channeled toward hexokinase bound to mitochondrial porin (VDAC) in beetroots (Beta vulgaris). Planta, 237(6):1571-1583.

[2]Cárdenas ML, Cornish-Bowden A, Ureta T, 1998. Evolution and regulatory role of the hexokinases. Biochim Biophys Acta, 1401(3):242-264.

[3]Chen FZ, Wang H, Lai JD, et al., 2018. 3-Bromopyruvate reverses hypoxia-induced pulmonary arterial hypertension through inhibiting glycolysis: in vitro and in vivo studies. Int J Cardiol, 266:236-241.

[4]Chen GH, Zhang YD, Liang JF, et al., 2018. Deregulation of hexokinase II is associated with glycolysis, autophagy, and the epithelial-mesenchymal transition in tongue squamous cell carcinoma under hypoxia. BioMed Res Int, 2018:8480762.

[5]de Meis L, Grieco MAB, Galina A, 1992. Reversal of oxidative phosphorylation in submitochondrial particles using glucose 6-phosphate and hexokinase as an ATP regenerating system. FEBS Lett, 308(2):197-201.

[6]Dewaal D, Nogueira V, Terry AR, et al., 2018. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun, 9:446.

[7]Dyląg M, Lis P, Niedźwiecka K, et al., 2013. 3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans. Biochem Biophys Res Commun, 434(2):322-327.

[8]el Sayed SM, Baghdadi H, Zolaly M, et al., 2017. The promising anticancer drug 3-bromopyruvate is metabolized through glutathione conjugation which affects chemoresistance and clinical practice: an evidence-based view. Med Hypotheses, 100:67-77.

[9]García-Espiñeira MC, Tejeda-Benítez LP, Olivero-Verbel J, 2018. Toxic effects of bisphenol A, propyl paraben, and triclosan on Caenorhabditis elegans. Int J Environ Res Public Health, 15(4):684.

[10]Guengerich FP, 2008. Cytochrome P450 and chemical toxicology. Chem Res Toxicol, 21(1):70-83.

[11]Huang RT, Huang Q, Wu GL, et al., 2017. Evaluation of the antioxidant property and effects in Caenorhabditis elegans of Xiangxi flavor vinegar, a Hunan local traditional vinegar. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 18(4):324-333.

[12]Kim JS, Ahn KJ, Kim JA, et al., 2008. Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells: ROS-mediated cell death by 3-BrPA. J Bioenerg Biomembr, 40(6):607-618.

[13]Kim W, Yoon JH, Jeong JM, et al., 2007. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma. Mol Cancer Ther, 6(9):2554-2562.

[14]Lai CH, Chou CY, Ch'ang LY, et al., 2000. Identification of novel human genes evolutionarily conserved in Caenorhabditis elegans by comparative proteomics. Genome Res, 10(5):703-713.

[15]Menzel R, Bogaert T, Achazi R, 2001. A systematic gene expression screen of Caenorhabditis elegans cytochrome P450 genes reveals CYP35 as strongly xenobiotic inducible. Arch Biochem Biophys, 395(2):158-168.

[16]Mycielska ME, Moser C, Wagner C, et al., 2012. Abstract 3211: inhibition of Hsp90 impairs expression of VDAC in plasma and mitochondrial membrane influencing cancer cell metabolism. Cancer Res, 72(S8):3211.

[17]Olsen BB, Gjedde A, Vilstrup MH, et al., 2019. Linked hexokinase and glucose-6-phosphatase activities reflect grade of ovarian malignancy. Mol Imaging Biol, 21(2):375-381.

[18]Patra KC, Hay N, 2013. Hexokinase 2 as oncotarget. Oncotarget, 4(11):1862-1863.

[19]Patra KC, Wang Q, Bhaskar PT, et al., 2013. Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer. Cancer Cell, 24(2):213-228.

[20]Qiao Y, Zhao YL, Wu QL, 2014. Full toxicity assessment of Genkwa Flos and the underlying mechanism in nematode Caenorhabditis elegans. PLoS ONE, 9(3):e91825.

[21]Roh JY, Choi J, 2011. Cyp35a2 gene expression is involved in toxicity of fenitrothion in the soil nematode Caenorhabditis elegans. Chemosphere, 84(10):1356-1361.

[22]Slein MW, Cori GT, Cori CF, 1950. A comparative study of hexokinase from yeast and animal tissues. J Biol Chem, 186(2):763-780.

[23]Wilson JE, 2003. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol, 206:2049-2057.

[24]Xu D, Jin JZ, Yu H, et al., 2017. Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2. J Exp Clin Cancer Res, 36(1):44.

[25]Yadav S, Pandey SK, Kumar A, et al., 2017a. Antitumor and chemosensitizing action of 3-bromopyruvate: implication of deregulated metabolism. Chem Biol Interact, 270:73-89.

[26]Yadav S, Pandey SK, Singh VK, et al., 2017b. Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: implication in designing of novel anticancer therapeutic strategies. PLoS ONE, 12(5):e0176403.